Turn Therapeutics Refines GX-03 Eczema Trial After Interim Data, Eyes 2026 Readout MarketBeat Source link
Significance of New Phase 3 Lebrikizumab Trial in Nummular Eczema, With Kilian Eyerich, MD, PhD HCPLive Source link
Johnson & Johnson Stock (JNJ) Update: Shares Hold Near $208 as Markets Close for the Weekend; Eczema Trial Halt, Pipeline Wins, and 2026 Outlook in Focus ts2.tech Source link
Eczema injectable drug provides quick itch relief, clinical trial results show Medical Xpress Source link